Which therapies will move to the front line for multiple myeloma? - Wikidata - awgldk - TriplyDB

Which therapies will move to the front line for multiple myeloma?

Which therapies will move to the front line for multiple myeloma?

http://www.wikidata.org/entity/Q38733592

about

Association of CD117 and HLA-DR expression with shorter overall survival and/or progression-free survival in patients with multiple myeloma treated with bortezomib and thalidomide combination treatment without transplantation

P2860

Q57788806-117F5787-9B45-414F-85B3-16F279AA83BF

P2860

Which therapies will move to the front line for multiple myeloma?

http://www.wikidata.org/entity/Q38733592

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Which therapies will move to the front line for multiple myeloma?

@en

type

label

Which therapies will move to the front line for multiple myeloma?

@en

prefLabel

Which therapies will move to the front line for multiple myeloma?

@en

P1433

Q38733592-A719C60C-4325-4AA5-B23C-3CC7622D2069

P1476

Q38733592-8184B817-2B41-4CA0-A68B-B07EE5EECD5A

P2093

Q38733592-0F872554-A07C-4A0B-ACE2-A27C1E4FB606

P2860

Q38733592-00D8F489-828C-4402-8638-BF961B1B780C

Q38733592-062AFB87-F5BE-46E7-B804-AB93DE8D5462

Q38733592-10192540-5266-4B16-B6C1-316B6C90EB44

Q38733592-14A9A53B-8B11-4BF2-8F94-35A57E57D923

Q38733592-16C71BE9-51C2-480F-9E35-6EBA2AEE9C52

Q38733592-1898DCF9-6286-4875-AA13-B87B94E00B55

Q38733592-198DA108-30D1-44BF-9CB4-A0F4ACFF78C9

Q38733592-1B4158F7-493D-45FC-9543-667FFE700B06

Q38733592-2176622F-927B-4E05-A760-D6E1BDE75471

Q38733592-2348DF1C-96C4-4B1C-98A8-4B79DACA9C38

P304

Q38733592-36F2C411-05D4-4C95-A8C2-CBF768897DDE

P31

Q38733592-1041CA41-573B-4E99-A6A8-2A83459812EF

P356

Q38733592-DB041315-3E45-4F41-B486-1B0C20C40E6B

P433

Q38733592-79B6B0C0-C736-4206-86F1-E1FC31715A76

P478

Q38733592-DCF8CC7D-5445-434C-B499-DDCD2B72BEDC

P50

Q38733592-4F5F8F1F-EAED-4EA7-98E0-D75817CF1CF9

P577

Q38733592-C25DABA8-DB29-412E-A593-DF82230A4549

P698

Q38733592-794710C2-BEAC-4827-8F11-F293872D3D30

P356

17474086.2017.1317589

P1433

Expert Review of Hematology

P1476

Which therapies will move to the front line for multiple myeloma?

@en

P2093

María J Cejalvo

http://www.w3.org/2001/XMLSchema#string

P2860

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma.

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.

Carfilzomib: a second-generation proteasome inhibitor for the treatment of multiple myeloma.

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

P304

383-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17474086.2017.1317589

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Javier de la Rubia

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28388244

http://www.w3.org/2001/XMLSchema#string